XORTX THERAPEUTICS INC (XRTX)
CA98420Q3061 - Common Stock
| MRQ (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | 71.65K | 95.00K | 3.82M | 13.92M | 126.46K | |||
| Cash Equivalents | 2.23M | 3.35M | 6.61M | N/A | N/A | |||
| Marketable Securities | N/A | N/A | N/A | 0.00 | 1.36M | |||
| Receivables | 13.11K | 60.71K | 81.75K | 36.94K | 43.66K | |||
| Other Current Assets | 96.54K | 560.41K | 379.62K | 910.60K | 0.00 | |||
| Total Current Assets | 2.41M | 4.07M | 10.90M | 14.46M | 1.54M | |||
| Non-Current Assets | ||||||||
| PPE Net | 54.23K | 23.93K | 92.68K | N/A | 0.00 | |||
| Investments And Advances | 1.20M | 1.20M | 1.19M | 1.15M | N/A | |||
| Intangibles | 185.70K | 175.25K | 199.83K | 183.65K | 174.98K | |||
| Other Non-Current Assets | N/A | N/A | N/A | N/A | N/A | |||
| Total Non-Current Assets | 1.44M | 1.40M | 1.48M | 1.33M | 174.98K | |||
| TOTAL ASSETS | 3.85M | 5.47M | 12.37M | 15.79M | 1.71M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 61.47K | 11.51K | 77.60K | N/A | 0.00 | |||
| Accrued Expenses | 215.55K | 87.61K | 151.41K | 208.06K | N/A | |||
| Accounts Payable | 110.74K | 195.81K | 1.29M | 294.35K | 772.32K | |||
| Other Current Liabilities | 1.33M | N/A | N/A | N/A | 0.00 | |||
| Total Current Liabilities | 1.72M | 294.94K | 1.52M | 502.40K | 772.32K | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | N/A | 531.00K | 3.85M | 3.29M | N/A | |||
| Total Non-Current Liabilities | 0.00 | 531.00K | 3.85M | 3.29M | 0.00 | |||
| TOTAL LIABILITIES | 1.72M | 825.94K | 5.38M | 3.80M | 772.32K | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -15.71M | -12.39M | -9.50M | -2.37M | -6.00M | |||
| Additional Paid In Capital | N/A | N/A | N/A | N/A | 0.00 | |||
| Common Shares | 17.90M | 17.08M | 16.55M | 14.36M | 6.19M | |||
| Other Shareholders' Equity | -52.61K | -52.61K | 6.14M | 4.77M | 749.47K | |||
| Shares Outstanding | 2.90M | 2.00M | 1.67M | 1.44M | 768.30K | |||
| Tangible Book Value per Share | 0.67 | 2.23 | 4.07 | 8.18 | 0.99 | |||
| Total Shareholders' Equity | 2.13M | 4.64M | 7.00M | 12.00M | 938.12K | |||
| TOTAL LIABILITIES AND EQUITY | 3.85M | 5.47M | 12.37M | 15.79M | 1.71M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | N/A | N/A | |||
| Current Ratio | 1.40 | 13.80 | 7.15 | 28.78 | 1.99 | |||
| Return On Assets (ROA) | -19.13% | -39.47% | -62.38% | -7.50% | -56.08% | |||
| Return On Equity (ROE) | -34.53% | -46.49% | -110.32% | -9.87% | -102.26% | |||
All data in USD , ROIC based on taxRate of 0.21